News Agency
Men's Weekly

Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Provisional Approval in New Zealand as a First and Second Booster for Adults

  • Written by PR Newswire
Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Provisional Approval in New Zealand as a First and Second Booster for Adults
  • Nuvaxovid™ is New Zealand's first and only protein-based COVID-19 vaccine
  • Nuvaxovid™ can now be used as a first or second booster dose for adults aged 18 and older vaccinated with any primary series vaccine

GAITHERSBURG, Md., Aug. 17, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and...

Read more: Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Provisional Approval in New Zealand as a...

Why Defence Recruitment Plays A Key Role In Supporting The Defence Industry

The defence sector is a vital part of national security and technological development. It supports military operations, research programs, and strategic planning that help protect national interests. As the defence sector continues to evolve, organisations rely on specialised hiring processes... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion